Work

Early toxicity, healthcare utilization, and survival after CAR T-cell therapy versus bispecific antibodies in DLBCL: A propensity-matched real-world analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.7041

Authors: Jatin Thukral, Kanishka Uttam Chandani, Ansy Patel, Riya Kaushal Shah, Sooraj Srirangadhamu Gopu, Vida Tajiknia, Nikhil Thukral, Diana Zamora, Sarah Elizabeth Monick, Ahmed Nadeem, Talal Hilal, Vishnu Yanamaladoddi

Institutions: New York Medical College, Mayo Clinic in Arizona, SUNY Upstate Medical University, Brown University, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), Creighton University

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162484086

Cites:

Cited by:

Related to: